PDX Model DetailsTM00016

Request more information on this PDX model.

Model Details

Model ID (Previous ID)
TM00016 (BL0293F)
Primary Site
Bladder
Tumor Site
Bladder
Tumor Type
Primary Malignancy
Initial Diagnosis
transitional cell carcinoma
Final Diagnosis
sarcomatoid transitional cell carcinoma
Stage/Grade
Not Specified / Grade:high

Publications citing this model

Pan, C; et al. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One 2015;10(8), p1-22. doi:10.1371/journal

Patient

Sex
Female
Age
77
Race/Ethnicity
White / Not Hispanic or Latino
Treatment Naïve
Yes

Engraftment Host

Strain
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
(aka NSG or NOD Scid gamma)
Sample Type
Surgical resection (fragment)

Variant Summary

Gene Expression

Platforms: RNA_Seq, hg10st

Hatched bars indicate genes with expression levels determined to be mildly affected by alignment calculations. Details.

Gene CNV

CNV Plots

Model Characterization

Histology: Summary:
P0 pathology consistent with sarcomatoid transitional cell carcinoma. P2 pathology consistent with poorly differentiated carcinoma.
Pathologist:
Dr. Regina Gandour-Edwards, University of California, Davis

Patient tumor for PDX model TM000016. High grade urothelial carcinoma invading bladder wall.

P0 tumor #563 for PDX model TM00016. Sheets of high grade urothelial carcinoma cells.

P0 tumor #563 for PDX model TM00016. Positive staining for Ki67 indicating tumor cells of human origin.

P0 tumor #563 for PDX model TM00016. Diffuse positivity for vimentin staining in tumor cells.

P2 tumor F563 ID015 for PDX model TM00016 stained for H&E.

P2 tumor F563 ID015 for PDX model TM00016 stained for AE1/AE3. Staining was positive.

P2 tumor F563 ID015 for PDX model TM00016 stained for CD45. Staining was negative.

P2 tumor F563 ID015 for PDX model TM00016 stained for Ki67. Staining was positive.
Circos Plots:

Circos plot for P0 tumor #563 from PDX model TM00016

Dosing Studies